Cite
HARVARD Citation
Ishibashi, Y. et al. (2015). Rivaroxaban inhibits oxidative and inflammatory reactions in advanced glycation end product-exposed tubular cells by blocking thrombin/protease-activated receptor-2 system. Thrombosis research. 135 (4), pp. 770-773. [Online].